Skip to main content
Denmark
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Aidian – Your aid in diagnostics
  • Produkter
  • Om os
  • Nyheder
  • Instrument service
  • Antimicrobial resistance
  • Messer og udstillinger
  • Aidian Academy
  • Kunde historier
Kontakt os Søg
Logo
Kontakt os
  • Point of care
  • Mikrobiologi
  • Molekylær mikrobiologi
  • Hygiejneovervågning
  • RIA / Collagener
  • Luftvejsinfektioner
  • Andre
Point of care
  • QuikRead go-systemet
  • microINR
  • Certest
  • FACIT
  • SD BIOSENSOR STANDARD F
  • bioLytical Laboratories INSTI®
  • Nova Biomedical
  • ACRO™ Biotech
  • Hangzhou AllTest Biotech
Læs mere
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go tilbehør
QuikRead go
Mikrobiologi
  • Uricult / Uricult Trio-tests
  • Uricult Vet
  • Cultura M
  • MIKROGEN serologi
  • Meridian Immunoassays
  • Meridian Curian®
  • Reagena
Læs mere
Molekylær mikrobiologi
  • Meridian Revogene®
  • Meridian Alethia®
  • MIKROGEN molecular diagnostics
  • SD BIOSENSOR STANDARD M10
Læs mere
Hygiejneovervågning
  • Easicult
  • Hygicult
  • Clean Card PRO
Læs mere
RIA / Collagener
  • UniQ RIA
Læs mere
Andre
  • Grifols Promonitor®
Læs mere
  • Aidian i Danmark
  • Bestyrelse og direktion
  • Bæredygtighed
  • Kultur
  • Karriere
  • Nyheder
  • Produktnyheder
  • AMR
  • Begivenheder
  • Stories from customers
  • COVID-19
  • Om C-reaktivt protein (CRP)
  • CRP and lower respiratory tract infections
  • Understøttende materialer
  • QuikRead go CRP products
  • Spreading of antibiotic resistant bacteria
  • Useful links
  • Generally
  • Product information
  • Documents and materials
  • Frequently asked questions
  • Sovehygiejne: overvågning af renlighed af puder og sengetøj
Logo
Kontakt os Tæt
  • Produkter
    • Point of care
      • QuikRead go-systemet
      • microINR
      • Certest
      • FACIT
      • SD BIOSENSOR STANDARD F
      • bioLytical Laboratories INSTI®
      • Nova Biomedical
      • ACRO™ Biotech
      • Hangzhou AllTest Biotech
    • Mikrobiologi
      • Uricult / Uricult Trio-tests
      • Uricult Vet
      • Cultura M
      • MIKROGEN serologi
      • Meridian Immunoassays
      • Meridian Curian®
      • Reagena
    • Molekylær mikrobiologi
      • Meridian Revogene®
      • Meridian Alethia®
      • MIKROGEN molecular diagnostics
      • SD BIOSENSOR STANDARD M10
    • Hygiejneovervågning
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Collagener
      • UniQ RIA
    • Luftvejsinfektioner
    • Andre
      • Grifols Promonitor®
  • Om os
    • Aidian i Danmark
    • Bestyrelse og direktion
    • Bæredygtighed
    • Kultur
    • Karriere
  • Nyheder
    • Nyheder
    • Produktnyheder
    • AMR
    • Begivenheder
    • Stories from customers
    • COVID-19
  • Instrument service
  • Antimicrobial resistance
    • Om C-reaktivt protein (CRP)
    • CRP and lower respiratory tract infections
    • Understøttende materialer
    • QuikRead go CRP products
    • Spreading of antibiotic resistant bacteria
    • Useful links
  • Messer og udstillinger
  • Aidian Academy
    • Generally
    • Product information
    • Documents and materials
    • Frequently asked questions
  • Kunde historier
    • Sovehygiejne: overvågning af renlighed af puder og sengetøj
Populære produkter
AllTest hCG hurtig test

AllTest hCG hurtig test

AllTest MONO hurtig test

AllTest MONO hurtig test

Acro Strep A hurtig test

Acro Strep A hurtig test

Seneste nyt
Se alt

Are you prepared for tick season?

9. april 2025 | Nyheder, Produktnyheder

Vi præsenterer QuikRead go Plus Instrument!

20. januar 2025 | Nyheder, Produktnyheder

Increase in influenza and RSV activity in the EU/EEA

14. januar 2025 | Nyheder

  • Se alt
  • Ingen resultater fundet
  • Loading...
Nyheder

Are you prepared for tick season?

9. april 2025 | Nyheder, Produktnyheder

Vi præsenterer QuikRead go Plus Instrument!

20. januar 2025 | Nyheder, Produktnyheder

Tilbage til alle nyheder
1. december 2020
AMR,
COVID-19

A significant decrease in Urinary tract infection (UTI) diagnoses due to the COVID-19 pandemic raises concern

The global SARS-CoV-2 pandemic changed primary care tremendously when persons with COVID-19 like symptoms were discouraged from visiting their GPs. This resulted in a decrease of patients accessing primary care services and a drop in diagnoses, including UTI. The weekly rate of UTI diagnosis per 100,000 population dropped from average of 30-35 to less than 10 between 30 March and 24 April 2020. Since April, the rate has risen no higher than 50% of the usual.

The pandemic resulted to fewer urine samples to be handed in. The fewer infections that are seen in primary care, the fewer antibiotics are prescribed. Whether this impact will be positive or negative to antimicrobial resistance (AMR) prevalence remains to be seen, but if we are not taking urine samples from those who have symptoms, we remain in the dark about the most appropriate management strategy and could therefore be encouraging bacterial resistance to antibiotics.

In recent years, clinicians have been encouraged to reduce the prescription of broad-spectrum antibiotics, including cefalexin, co-amoxiclav, and ciprofloxacin. Interestingly, prescribing of all these antibiotics for the elderly in England has increased since March 2020. The pressure to manage elderly patients at home during the pandemic could have led to the increase. Broad-spectrum antibiotics are often favored when clinicians do not know what is causing the patient’s symptoms, nor which antibiotic will be most effective. Of greater concern, however, is the 30% decrease observed in the number of sepsis hospital admissions between March and April 2020. Non-COVID-19 related deaths at home in England increased by almost 47% during the same

time period which raises the question of whether sepsis patients are being missed due to changes in patient management brought about by COVID-19.

The true impact of the pandemic on the management of common community-acquired infections including UTIs remains unknown, and certainly presents a unique opportunity for a natural experiment in terms of AMR.

Read the entire article by Dr Ashley Hammond, Senior Research Associate, University of Bristol at https://www.bsac.org.uk/plumme...

Share
Facebook
Twitter
E-mail

Aidian Denmark ApS

Ørestads Boulevard 73,
2300 København S


+45 8610 3020


Forespørgsler
info@aidian.dk


Salg
order@aidian.dk

Selskab
  • Om os
  • Bæredygtighed
  • Karriere
  • Kontakt os
Produkter
  • Point of care
  • Mikrobiologi
  • Molekylær mikrobiologi
  • Hygiejneovervågning
  • RIA / Collagener
  • Luftvejsinfektioner
  • Andre
Hurtige links
  • Aidian Academy
Copyright © 2025 Aidian
  • Persondatapolitik
  • Erklæring om beskyttelse af persondata
  • Cookie-politik
  • Sociale medier politik